Catalog Number CDS0702-XTW |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problems
Endocarditis (1834); Sepsis (2067); Heart Failure/Congestive Heart Failure (4446); Insufficient Information (4580)
|
Event Date 10/14/2022 |
Event Type
Death
|
Event Description
|
This report is being conservatively filed for patient death.Patient id: (b)(6).It was reported that on (b)(6) 2022, the patient presented with functional mitral regurgitation (mr) grade 4+, with mitral annular calcification and leaflet tethering.One mitraclip was implanted, reducing the mr to grade 2+.There was no device deficiency.On (b)(6) 2022, the patient had expired.The cause of death was unknown.Reportedly, additional details are not available at this time.No additional information was provided regarding this issue.
|
|
Manufacturer Narrative
|
Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
|
|
Manufacturer Narrative
|
The device was not returned for analysis.A review of the lot history record revealed no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Based on available information, causes for the reported endocarditis, sepsis, and heart failure could not be determined.The reported death appears to be due to worsening patient condition.Additionally, the reported patient effects of death, endocarditis, sepsis, and heart failure are listed in the instructions for use as a known possible complications associated with mitraclip procedures.The reported medication and hospitalization were the results of case-specific circumstances.There is no indication of a product issue with respect to manufacture, design, or labeling.
|
|
Event Description
|
Subsequent to the previous report, the additional information was received: on (b)(6) 2022, the patient had been admitted to the hospital with worsening heart failure, cardiovascular infection, and sepsis.Endocarditis of the mitral valve was noted, treated with medications.A myocardial infarction was also diagnosed, treated with a percutaneous coronary intervention with stent placement.Per physician, the myocardial infarction was unrelated to the mitraclip device.On (b)(6) 2022, the patient had expired.
|
|
Search Alerts/Recalls
|
|